Alpha Cognition is trading at $9.09 (6.7% up) in pre-market. - Raymond James initiated coverage on Alpha Cognition Inc. (NASDAQ:ACOG) with an Outperform rating and a price target of $20.00 on July 10, 2026. - The firm noted Alpha Cognition markets Zunveyl (benzgalantamine) for mild-to-moderate dementia in Alzheimer's disease.